Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
Income Statement
Earnings Waterfall
Qianjiang Yongan Pharmaceutical Co Ltd
Revenue
|
1.1B
CNY
|
Cost of Revenue
|
-758.9m
CNY
|
Gross Profit
|
383.3m
CNY
|
Operating Expenses
|
-359.9m
CNY
|
Operating Income
|
23.3m
CNY
|
Other Expenses
|
1.8m
CNY
|
Net Income
|
25.1m
CNY
|
Income Statement
Qianjiang Yongan Pharmaceutical Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
542
N/A
|
523
-4%
|
535
+2%
|
562
+5%
|
594
+6%
|
658
+11%
|
661
+0%
|
681
+3%
|
598
-12%
|
556
-7%
|
542
-3%
|
544
+1%
|
567
+4%
|
549
-3%
|
606
+10%
|
688
+14%
|
766
+11%
|
933
+22%
|
982
+5%
|
1 011
+3%
|
1 016
+0%
|
1 005
-1%
|
1 057
+5%
|
1 143
+8%
|
1 288
+13%
|
1 370
+6%
|
1 310
-4%
|
1 307
0%
|
1 252
-4%
|
1 173
-6%
|
1 268
+8%
|
1 304
+3%
|
1 407
+8%
|
1 565
+11%
|
1 664
+6%
|
1 680
+1%
|
1 563
-7%
|
1 462
-6%
|
1 361
-7%
|
1 214
-11%
|
1 142
-6%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(440)
|
(439)
|
(465)
|
(482)
|
(505)
|
(558)
|
(556)
|
(582)
|
(503)
|
(461)
|
(440)
|
(430)
|
(442)
|
(409)
|
(455)
|
(493)
|
(510)
|
(595)
|
(609)
|
(625)
|
(641)
|
(656)
|
(755)
|
(863)
|
(1 003)
|
(1 053)
|
(1 023)
|
(937)
|
(885)
|
(820)
|
(886)
|
(965)
|
(1 035)
|
(1 212)
|
(1 277)
|
(1 293)
|
(1 193)
|
(991)
|
(914)
|
(788)
|
(759)
|
|
Gross Profit |
102
N/A
|
84
-17%
|
71
-16%
|
80
+12%
|
89
+12%
|
101
+14%
|
106
+5%
|
98
-7%
|
95
-3%
|
95
0%
|
102
+7%
|
114
+12%
|
125
+9%
|
141
+13%
|
152
+8%
|
196
+29%
|
256
+31%
|
338
+32%
|
373
+10%
|
387
+4%
|
374
-3%
|
350
-7%
|
302
-14%
|
281
-7%
|
284
+1%
|
318
+12%
|
287
-10%
|
370
+29%
|
367
-1%
|
353
-4%
|
382
+8%
|
338
-11%
|
372
+10%
|
354
-5%
|
387
+9%
|
387
+0%
|
370
-5%
|
471
+27%
|
447
-5%
|
426
-5%
|
383
-10%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(63)
|
(68)
|
(66)
|
(66)
|
(71)
|
(78)
|
(82)
|
(91)
|
(98)
|
(99)
|
(104)
|
(100)
|
(96)
|
(101)
|
(98)
|
(107)
|
(120)
|
(162)
|
(191)
|
(177)
|
(181)
|
(155)
|
(158)
|
(170)
|
(178)
|
(198)
|
(204)
|
(210)
|
(214)
|
(216)
|
(263)
|
(278)
|
(297)
|
(226)
|
(220)
|
(209)
|
(199)
|
(296)
|
(369)
|
(363)
|
(360)
|
|
Selling, General & Administrative |
(64)
|
(63)
|
(64)
|
(62)
|
(64)
|
(69)
|
(74)
|
(81)
|
(88)
|
(88)
|
(95)
|
(95)
|
(93)
|
(91)
|
(94)
|
(103)
|
(115)
|
(111)
|
(163)
|
(170)
|
(170)
|
(128)
|
(148)
|
(146)
|
(145)
|
(143)
|
(139)
|
(149)
|
(154)
|
(171)
|
(201)
|
(215)
|
(241)
|
(169)
|
(172)
|
(163)
|
(156)
|
(252)
|
(303)
|
(293)
|
(290)
|
|
Research & Development |
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
(2)
|
(47)
|
0
|
0
|
(7)
|
(24)
|
(18)
|
(35)
|
(45)
|
(54)
|
(49)
|
(46)
|
(44)
|
(47)
|
(55)
|
(54)
|
(54)
|
(50)
|
(50)
|
(49)
|
(47)
|
(37)
|
(40)
|
(42)
|
(44)
|
|
Depreciation & Amortization |
0
|
(3)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
|
Other Operating Expenses |
1
|
(0)
|
(2)
|
(4)
|
(6)
|
(0)
|
(8)
|
(10)
|
(10)
|
(0)
|
(9)
|
(5)
|
(4)
|
(0)
|
(3)
|
(4)
|
(3)
|
4
|
(29)
|
(5)
|
(4)
|
5
|
9
|
11
|
12
|
7
|
(16)
|
(15)
|
(16)
|
10
|
(8)
|
(8)
|
(2)
|
4
|
2
|
2
|
4
|
6
|
(26)
|
(28)
|
(27)
|
|
Operating Income |
39
N/A
|
16
-58%
|
5
-71%
|
14
+187%
|
18
+34%
|
23
+25%
|
23
+2%
|
8
-68%
|
(3)
N/A
|
(4)
-37%
|
(2)
+54%
|
14
N/A
|
29
+101%
|
40
+41%
|
54
+34%
|
89
+64%
|
137
+54%
|
176
+29%
|
182
+3%
|
210
+16%
|
193
-8%
|
195
+1%
|
144
-26%
|
111
-23%
|
106
-4%
|
119
+13%
|
83
-31%
|
160
+94%
|
153
-4%
|
137
-11%
|
119
-13%
|
61
-49%
|
75
+24%
|
128
+70%
|
167
+30%
|
178
+7%
|
170
-4%
|
176
+3%
|
78
-56%
|
63
-19%
|
23
-63%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
5
|
6
|
7
|
11
|
13
|
13
|
15
|
15
|
19
|
21
|
18
|
21
|
18
|
24
|
24
|
18
|
14
|
6
|
(2)
|
9
|
20
|
23
|
35
|
31
|
26
|
28
|
22
|
20
|
18
|
15
|
18
|
16
|
14
|
17
|
12
|
28
|
40
|
26
|
32
|
32
|
25
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(1)
|
0
|
(1)
|
(3)
|
(30)
|
0
|
(19)
|
(19)
|
(5)
|
0
|
(4)
|
(2)
|
(31)
|
0
|
0
|
(6)
|
(20)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
1
|
(50)
|
0
|
(0)
|
(0)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
5
|
5
|
6
|
4
|
4
|
6
|
5
|
6
|
6
|
7
|
8
|
11
|
13
|
11
|
15
|
12
|
9
|
5
|
(1)
|
(3)
|
(1)
|
(0)
|
(6)
|
(3)
|
(5)
|
0
|
5
|
1
|
(1)
|
(1)
|
(3)
|
(3)
|
(3)
|
1
|
(2)
|
(4)
|
(1)
|
1
|
1
|
(4)
|
(2)
|
|
Pre-Tax Income |
48
N/A
|
28
-42%
|
17
-37%
|
28
+62%
|
35
+24%
|
37
+6%
|
42
+14%
|
29
-33%
|
22
-24%
|
21
-4%
|
25
+18%
|
46
+86%
|
59
+30%
|
73
+24%
|
93
+27%
|
119
+27%
|
157
+32%
|
157
N/A
|
180
+14%
|
198
+10%
|
194
-2%
|
212
+9%
|
172
-19%
|
133
-22%
|
125
-7%
|
116
-7%
|
110
-5%
|
181
+65%
|
165
-9%
|
131
-21%
|
134
+3%
|
74
-45%
|
86
+17%
|
130
+50%
|
177
+36%
|
202
+14%
|
209
+4%
|
153
-27%
|
111
-28%
|
91
-18%
|
46
-49%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(8)
|
(5)
|
(3)
|
(6)
|
(7)
|
(6)
|
(6)
|
(4)
|
(3)
|
(4)
|
(4)
|
(7)
|
(9)
|
(11)
|
(14)
|
(19)
|
(25)
|
(24)
|
(28)
|
(31)
|
(30)
|
(33)
|
(28)
|
(18)
|
(13)
|
(9)
|
(6)
|
(16)
|
(15)
|
(12)
|
(13)
|
(4)
|
(5)
|
(11)
|
(17)
|
(23)
|
(25)
|
(20)
|
(14)
|
(13)
|
(27)
|
|
Income from Continuing Operations |
41
|
23
|
14
|
23
|
29
|
32
|
36
|
25
|
19
|
17
|
20
|
38
|
50
|
62
|
79
|
100
|
132
|
133
|
152
|
167
|
164
|
179
|
144
|
115
|
111
|
107
|
104
|
166
|
150
|
119
|
121
|
69
|
81
|
119
|
160
|
179
|
184
|
133
|
96
|
78
|
19
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
1
|
(0)
|
(4)
|
(10)
|
(15)
|
(17)
|
(16)
|
(15)
|
(15)
|
(13)
|
(13)
|
(11)
|
(8)
|
(8)
|
(6)
|
2
|
7
|
8
|
8
|
2
|
6
|
|
Net Income (Common) |
41
N/A
|
23
-43%
|
14
-38%
|
23
+59%
|
29
+25%
|
32
+11%
|
36
+14%
|
25
-31%
|
19
-23%
|
18
-8%
|
21
+17%
|
39
+89%
|
50
+30%
|
62
+24%
|
79
+27%
|
100
+26%
|
132
+32%
|
133
+1%
|
152
+14%
|
168
+10%
|
164
-2%
|
179
+9%
|
140
-22%
|
106
-25%
|
97
-9%
|
90
-7%
|
88
-2%
|
151
+71%
|
135
-11%
|
106
-22%
|
108
+3%
|
59
-46%
|
73
+25%
|
111
+52%
|
154
+38%
|
181
+17%
|
191
+5%
|
140
-26%
|
105
-25%
|
80
-24%
|
25
-69%
|
|
EPS (Diluted) |
0.15
N/A
|
0.08
-47%
|
0.05
-38%
|
0.08
+60%
|
0.1
+25%
|
0.11
+10%
|
0.12
+9%
|
0.08
-33%
|
0.06
-25%
|
0.06
N/A
|
0.07
+17%
|
0.14
+100%
|
0.18
+29%
|
0.22
+22%
|
0.28
+27%
|
0.35
+25%
|
0.46
+31%
|
0.47
+2%
|
0.53
+13%
|
0.59
+11%
|
0.55
-7%
|
0.61
+11%
|
0.49
-20%
|
0.36
-27%
|
0.32
-11%
|
0.31
-3%
|
0.3
-3%
|
0.51
+70%
|
0.46
-10%
|
0.37
-20%
|
0.37
N/A
|
0.2
-46%
|
0.27
+35%
|
0.38
+41%
|
0.5
+32%
|
0.64
+28%
|
0.65
+2%
|
0.48
-26%
|
0.37
-23%
|
0.27
-27%
|
0.09
-67%
|